NCT03725085View on ClinicalTrials.gov

Study to Evaluate the Safety and Tolerability of Mucinex™(Guaifenesin) 600 mg Extended-Release Bi-Layer Tablets in the Treatment of Otherwise Healthy Patients With Symptoms of Cough, Thickened Mucus and Chest Congestion

PHASE4CompletedINTERVENTIONAL

Enrollment

552

Participants

Timeline

Start Date

January 24, 2015

Primary Completion Date

October 16, 2015

Study Completion Date

October 16, 2015

Conditions

Healthy Subjects

Interventions

DRUG

Mucinex™ extended-release (SE)

2 tablets of Mucinex™ (GGE, 600 mg extended-release bi-layer tablets)

All Listed Sponsors

lead

Reckitt Benckiser LLC

INDUSTRY

NCT03725085 - Study to Evaluate the Safety and Tolerability of Mucinex™(Guaifenesin) 600 mg Extended-Release Bi-Layer Tablets in the Treatment of Otherwise Healthy Patients With Symptoms of Cough, Thickened Mucus and Chest Congestion | Biotech Hunter | Biotech Hunter